As klotho promoter methylation has been confirmed in cancer cells [28], Wang et al. [7] suggested the possibility of developing cancer treatment using klotho promoter demethylation with 5-aza-2′-deoxycytidine, resulting in an increased klotho expression. Here, KL is linked to cancer.